Citation Tools
PDFLupus
Original research
Long-term open-label continuation study of the safety and efficacy of belimumab for up to 7 years in patients with systemic lupus erythematosus from Japan and South Korea
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Long-term open-label continuation study of the safety and efficacy of belimumab for up to 7 years in patients with systemic lupus erythematosus from Japan and South Korea